NADPH Oxidase–Mediated ROS in Pulmonary Arterial Hypertension

A special issue of Antioxidants (ISSN 2076-3921). This special issue belongs to the section "Antioxidant Enzyme Systems".

Deadline for manuscript submissions: closed (31 January 2019) | Viewed by 10367

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pharmacology and Toxicology, Medical College of Georgia, Augusta University, 1460 Laney Walker Blvd, CB3626, Augusta, GA 30912, USA
Interests: reactive oxygen species (ROS); NADPH oxidase; Galectin-3; PAH; vascular remodeling; redox signaling; adventitia; inflammation; vascular biology

Special Issue Information

Dear Colleagues,

Pulmonary arterial hypertension (PAH) is a progressive disease that involves the loss of endothelial function together with aberrant smooth muscle cell growth, inflammation, and fibrosis that involves multiple cell types in the pulmonary arteries (PA). How PAH develops remains incompletely understood, but evidence for production of reactive oxygen species (ROS) in PA has been well documented. There are many different types of ROS with multiple sources that may contribute to the pulmonary arterial remodeling that is a hallmark of PAH. The NADPH oxidase (Nox) family is comprised of seven structurally related transmembrane NADPH-dependent oxidoreductases that include the Nox enzymes, as well as the Duoxes. Accumulating evidence strongly suggests that ROS derived from NADPH oxidase play an important role in pulmonary arterial remodeling. The signaling mechanisms leading to activation of the Nox enzymes are diverse, and more precise targeting of the major sources of ROS in specific cell types in PA will likely be more effective towards development of therapeutic treatments for PAH.

The goal of this Special Issue is to bring together and outline the current state and importance of the role of NADPH oxidases in the context of PAH. Suppressing pathophysiological levels of ROS by manipulating NOX enzymes, their regulators, and effector ROS targets appears to be attractive therapeutic strategies to treat PAH and other related pulmonary vascular diseases. This Special Issue invites original research and review articles on the subject of NADPH-oxidases in the context of pulmonary vascular pathophysiology and all the related topics indicated below:

Prof. Scott A. Barman
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antioxidants is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Reactive Oxygen Species 
  • Inflammation 
  • Pulmonary Arterial Hypertension 
  • Redox Signaling 
  • Endothelial Cell 
  • Pulmonary Arterial Remodeling 
  • Adventitia 
  • Fibrosis

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

30 pages, 2810 KiB  
Review
Role of Gender in Regulation of Redox Homeostasis in Pulmonary Arterial Hypertension
by Ruslan Rafikov, Joel James, Nolan McClain, Stevan P. Tofovic and Olga Rafikova
Antioxidants 2019, 8(5), 135; https://doi.org/10.3390/antiox8050135 - 16 May 2019
Cited by 10 | Viewed by 5227
Abstract
Pulmonary arterial hypertension (PAH) is one of the diseases with a well-established gender dimorphism. The prevalence of PAH is increased in females with a ratio of 4:1, while poor survival prognosis is associated with the male gender. Nevertheless, the specific contribution of gender [...] Read more.
Pulmonary arterial hypertension (PAH) is one of the diseases with a well-established gender dimorphism. The prevalence of PAH is increased in females with a ratio of 4:1, while poor survival prognosis is associated with the male gender. Nevertheless, the specific contribution of gender in disease development and progression is unclear due to the complex nature of the PAH. Oxidative and nitrosative stresses are important contributors in PAH pathogenesis; however, the role of gender in redox homeostasis has been understudied. This review is aimed to overview the possible sex-specific mechanisms responsible for the regulation of the balance between oxidants and antioxidants in relation to PAH pathobiology. Full article
(This article belongs to the Special Issue NADPH Oxidase–Mediated ROS in Pulmonary Arterial Hypertension)
Show Figures

Figure 1

14 pages, 656 KiB  
Review
Regulation of Smooth Muscle Cell Proliferation by NADPH Oxidases in Pulmonary Hypertension
by John C. Huetsch, Karthik Suresh and Larissa A. Shimoda
Antioxidants 2019, 8(3), 56; https://doi.org/10.3390/antiox8030056 - 5 Mar 2019
Cited by 25 | Viewed by 4704
Abstract
Hyperproliferation of pulmonary arterial smooth muscle cells is a key component of vascular remodeling in the setting of pulmonary hypertension (PH). Numerous studies have explored factors governing the changes in smooth muscle cell phenotype that lead to the increased wall thickness, and have [...] Read more.
Hyperproliferation of pulmonary arterial smooth muscle cells is a key component of vascular remodeling in the setting of pulmonary hypertension (PH). Numerous studies have explored factors governing the changes in smooth muscle cell phenotype that lead to the increased wall thickness, and have identified various potential candidates. A role for reactive oxygen species (ROS) has been well documented in PH. ROS can be generated from a variety of sources, including mitochondria, uncoupled nitric oxide synthase, xanthine oxidase, and reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. In this article, we will review recent data supporting a role for ROS generated from NADPH oxidases in promoting pulmonary arterial smooth muscle cell proliferation during PH. Full article
(This article belongs to the Special Issue NADPH Oxidase–Mediated ROS in Pulmonary Arterial Hypertension)
Show Figures

Figure 1

Back to TopTop